Category: AZD-1222

  • Concerns emerge after AZ’s lucky vaccine trial ‘mistake’

    AstraZeneca may have tried a positive spin on the trial mistake that led to the accidental discovery of the low dose COVID-19 vaccine regime with the highest efficacy– but the revelation has drawn a mixed response from commentators. The company’s share price has tumbled since the announcement of the trial results from AZD-1222 at the […]